About CytoDyn Inc.


  • Ticker CYDY
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 813,040,000
  • Market Cap $97.6M
  • Description
  • CytoDyn Inc. operates as a clinical-stage biotechnology company. The company focuses on developing treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor in the areas of human immunodeficiency virus (HIV), non-alcoholic steatohepatitis (NASH), oncology, and such as c...
More about CYDY
Track This Portfolio

Track Caz Investments LP Portfolio

Follow Caz Investments LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caz Investments LP, based on Form 13F filings with the SEC.

News

Stay updated on Caz Investments LP with notifications on news.